普萘洛尔缩短分娩时间:随机对照试验的Meta分析
本Meta分析纳入9项随机对照试验共1182例患者,评估普萘洛尔对引产或催产患者分娩时间的影响。引产患者使用普萘洛尔显著缩短分娩时间(均数差-91.5分钟,95%CI -110.6至-72.4),催产患者无显著缩短(均数差-2.98分钟,95%CI -21.6至15.6)。汇总分析显示普萘洛尔组较安慰剂组分娩时间缩短(均数差-46.15分钟,95%CI -59.48至-32.81),且未增加产后出血、输血、剖宫产或新生儿重症监护室入院风险。
要点
- 引产患者使用普萘洛尔显著缩短分娩时间约91分钟。
- 催产患者使用普萘洛尔未显著缩短分娩时间。
- 普萘洛尔未增加产后出血、输血、剖宫产或新生儿重症监护室入院风险。
核心结论
- 引产期间使用普萘洛尔可将总分娩时间缩短约91分钟,而在催产患者中未显著缩短分娩时间。
研究设计与样本
- 随机对照试验的Meta分析,检索PubMed、Scopus、Cochrane Library、ClinicalTrials.gov和CINAHL(EBSCO)从建库至2023年12月。
- 纳入9项随机对照试验共1182例患者,其中5项研究引产患者,4项研究催产患者。
主要发现
- 引产患者使用普萘洛尔显著缩短分娩时间(均数差-91.5分钟,95%CI -110.6至-72.4)。
- 催产患者使用普萘洛尔未显著缩短分娩时间(均数差-2.98分钟,95%CI -21.6至15.6)。
- 汇总分析显示普萘洛尔组较安慰剂组分娩时间缩短(均数差-46.15分钟,95%CI -59.48至-32.81)。
- Meta分析未发现普萘洛尔增加产后出血、输血、剖宫产率或新生儿重症监护室入院风险。
关键数值与推荐
- 引产患者分娩时间均数差-91.5分钟(95%CI -110.6至-72.4)。
- 催产患者分娩时间均数差-2.98分钟(95%CI -21.6至15.6)。
- 汇总分娩时间均数差-46.15分钟(95%CI -59.48至-32.81)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effect of propranolol on time to delivery among patients undergoing induction or augmentation of labor. DATA SOURCES: PubMed, Scopus, Cochrane Library, ClinicalTrials.gov, and CINAHL (EBSCO) were searched from inception to December 2023. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials (RCTs) that examined the impact of propranolol on time to delivery among patients undergoing induction or augmentation of labor were included. RCTs that included stillbirth before randomization, non-randomized trials, observational, cohort, case control, or studies in which the control group included an intervention other than standard care were excluded. STUDY APPRAISAL AND SYNTHESIS METHODS: Primary outcome was time to delivery after administration of propranolol among patients undergoing induction or augmentation of labor. The summary measures were reported as summary mean difference (MD) or relative risk with 95% confidence interval (CI). RESULTS: Nine RCTs including 1,182 patients were included in this meta-analysis. Five studies investigated the effect of propranolol among patients undergoing induction of labor (IOL) and demonstrated a significant decrease in time to delivery (MD, -91.5 minutes, 95% CI -110.6 to -72.4). Four studies investigated the effect of propranolol among patients undergoing augmentation of labor and showed no significant decrease in time to delivery (MD, -2.98 minutes, 95% CI -21.6 to 15.6). Our pooled analysis demonstrated that the use of propranolol in IOL and augmentation was associated with a decrease in time to delivery from administration of propranolol compared to placebo (mean difference, -46.15 minutes, 95% CI -59.48 to -32.81). The meta-analysis found no increased risk of PPH, blood transfusion, cesarean delivery rates, or NICU admission with the use of propranolol during labor. CONCLUSION: The use of propranolol during induction of labor shortens overall time to delivery by about 91 minutes and did not significantly decrease time to delivery in those undergoing augmentation of labor.
引用
- Biswas S, Toro M, Horgan R, et al. Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2024. PMID: 39117277. doi:10.1016/j.ajogmf.2024.101459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。